Azilsartan medoxomil: Angiotensin receptor blocker in the treatment of hypertension.
Loading...
Date
2013-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Hypertension is an important risk factor for cardiovascular and renal
disease. It’s early detection and control is critically important as it is an
important attributable cause of stroke, coronary artery disease, heart
failure, atrial fibrillation and ESRD. Recent data indicates increasing
prevalence of hypertension amongst various populations. This reflects
the importance of having a variety of treatment options for the
management of this condition. Angiotensin receptor blockers are
highly effective at reducing blood pressure, have excellent tolerability
and renoprotective properties, hence they remain a useful choice in the
management of hypertension. Azilsartan medoxomil has recently been
approved by the FDA for the oral treatment of hypertension making it
the eighth Angiotensin receptor blocker to be approved for this
indication.
Description
Keywords
Hypertension, Azilsartan, angiotensin receptor blocker
Citation
Sood M, Bajaj JK. Azilsartan medoxomil: Angiotensin receptor blocker in the treatment of hypertension. International Journal of Medical and Dental Sciences. 2013 Jan; 2(1): 100-103.